Avanzanite secures €32m Series A funding Avanzanite Bioscience NV has raised €32m in a Series A financing round from MVM Partners, marking the company’s first institutional investment since its founding in 2022. The funding will support the expansion of Avanzanite’s operational infrastructure across 32 European countries, accelerate the commercialisation of existing and upcoming orphan drugs, and enable the company to form new […] Written by Thomas Gabrielczyk November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
Азартные игры новый взгляд на мир ставок и страстей Азартные игры новый взгляд на мир ставок и страстей История азартных игр Азартные игры имеют длинную и увлекательную историю, уходящую корнями в древние цивилизации. С момента появления первых игральных костей и карточных игр, азартные игры привлекали внимание людей своей непредсказуемостью и возможностью выиграть. В различные исторические эпохи азартные игры имели разные формы, но суть оставалась […] Written by yam3t3 November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
Avanzanite secures €32m Series A funding Avanzanite Bioscience NV has raised €32m in a Series A financing round from MVM Partners, marking the company’s first institutional investment since its founding in 2022. The funding will support the expansion of Avanzanite’s operational infrastructure across 32 European countries, accelerate the commercialisation of existing and upcoming orphan drugs, and enable the company to form new […] Written by Thomas Gabrielczyk November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
Азартные игры новый взгляд на мир ставок и страстей Азартные игры новый взгляд на мир ставок и страстей История азартных игр Азартные игры имеют длинную и увлекательную историю, уходящую корнями в древние цивилизации. С момента появления первых игральных костей и карточных игр, азартные игры привлекали внимание людей своей непредсказуемостью и возможностью выиграть. В различные исторические эпохи азартные игры имели разные формы, но суть оставалась […] Written by yam3t3 November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
A new probe illuminates endo-lysosomal Ca 2+ measurements: A role for vesicular IP 3 receptors? In this issue, Calvo et al. (https://doi.org/10.1083/jcb.202410094) report a new bioluminescent Ca2+ probe (ELGA) targeted to acidic endo-lysosomes (ELs) to permit selective and dynamic recording of endo-lysosomal Ca2+ uptake and release. Ca2+ was not only released by canonical EL channels but, surprisingly, by IP3 receptors. Written by Admin November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
